Cite Filings / SABS / 0000950170-22-009899

Feed Companies Filings Check

Sign in

424B3

Prospectus

SAB Biotherapeutics, Inc. Filed 2022-05-16 Acc 0000950170-22-009899

Documents 1

424B3 Prospectus , sabs-424b3-resale_s-1-10.htm

Around this filing

2022-06-07 424B3 Prospectus
2022-05-23 4 Director acquired 299,002 shares (other)
2022-05-23 4 Executive Chairman disposed of 2,500,127 shares (other)
2022-05-16 424B3 Prospectus
2022-05-12 10-Q Quarterly Report
2022-04-29 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading sabs-424b3-resale_s-1-10.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…